BILIARY ATRESIA
Clinical trials for BILIARY ATRESIA explained in plain language.
Never miss a new study
Get alerted when new BILIARY ATRESIA trials appear
Sign up with your email to follow new studies for BILIARY ATRESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could buy time for kids with rare liver disease
Disease control OngoingThis study tests an experimental drug called odevixibat in children with biliary atresia who have already had Kasai surgery. The goal is to see if the drug can delay or prevent the need for a liver transplant and improve survival. About 254 children will receive either odevixibat…
Matched conditions: BILIARY ATRESIA
Phase: PHASE3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated May 12, 2026 13:44 UTC
-
New hope for kids with rare liver disease: drug may delay transplant
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety and effectiveness of odevixibat in children with biliary atresia, a rare liver disease. The main goal is to see if the drug helps children stay alive without needing a liver transplant. About 180 children who completed a previous study will t…
Matched conditions: BILIARY ATRESIA
Phase: PHASE3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Researchers dig into 150 Kids' records to unlock biliary atresia secrets
Knowledge-focused OngoingThis study looks back at the medical records of 150 children with biliary atresia, a rare liver disease in infants. Researchers want to find out which treatments and factors lead to better outcomes, like avoiding liver transplants. The goal is to use this information to improve c…
Matched conditions: BILIARY ATRESIA
Sponsor: Yale University • Aim: Knowledge-focused
Last updated May 08, 2026 12:01 UTC